+ − Summary
+ − Full Texts (2)
+ − Actions (27)
- Session Sine Die
- Arrive in Senate
- Placed on Calendar Order of First Reading
- Chief Senate Sponsor Sen. Don Harmon
- First Reading
- Referred to Assignments
- Motion Filed to Reconsider Vote Rep. Norine K. Hammond
- Motion to Reconsider Vote - Withdrawn Rep. Norine K. Hammond
- Final Action Deadline Extended-9(b) April 8, 2022
- Approved for Consideration Rules Committee; 003-001-000
- Placed on Calendar 2nd Reading - Short Debate
- House Floor Amendment No. 1 Filed with Clerk by Rep. Will Guzzardi
- House Floor Amendment No. 1 Referred to Rules Committee
- House Floor Amendment No. 1 Recommends Be Adopted Rules Committee; 003-002-000
- Chief Sponsor Changed to Rep. Will Guzzardi
- House Floor Amendment No. 1 Adopted 098-000-000
- Placed on Calendar Order of 3rd Reading - Short Debate
- Third Reading - Short Debate - Passed 101-000-000
- Rule 19(a) / Re-referred to Rules Committee
- Second Reading - Short Debate
- Held on Calendar Order of Second Reading - Short Debate **
- Placed on Calendar 2nd Reading - Short Debate **
- Do Pass / Short Debate Executive Committee; 014-000-000
- Assigned to Executive Committee
- First Reading
- Referred to Rules Committee
- Filed with the Clerk by Rep. Emanuel Chris Welch
+ − Adopted Amendment
House Amendment 001
Replaces everything after the enacting clause. Creates the Access to Affordable Insulin Act. Sets forth provisions concerning an insulin urgent-need program. Provides that by July 1, 2022, each manufacturer shall establish procedures to make insulin available to eligible individuals who are in urgent need of insulin or who are in need of access to an affordable insulin supply. Sets forth provisions concerning insulin urgent-need program exceptions, eligibility, forms, applications, claims and reimbursement, copayments, information sheets, navigators, and penalties. Defines terms. Amends the Illinois Insurance Code. In provisions concerning cost sharing in prescription insulin drugs, provides that an insurer that provides coverage for prescription insulin drugs under the terms of a health coverage plan the insurer offers shall limit the total amount that an insured is required to pay for a 30-day supply of covered prescription insulin drugs at an amount not to exceed $35 (rather than $100). Effective immediately.
+ − Proposed Amendment
+ − Statutes Amended (3)
- 215 ILCS 5/351A-4 - from Ch. 73, par. 963A-4
- New Act
- 215 ILCS 5/356z.41